Science Explorer Interactive view Map
Company · Boston · United States

Acetylon Pharmaceuticals (United States)

acetylon.comROR OpenAlex
Research works
41
▼ 94% vs 2013–17
Citations
840
20.4 per fractional work
Top-10% rate
24.2%
record average 16.5%
Open access
24%
world 28%

Not ranked overall: Acetylon Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Acetylon Pharmaceuticals (United States)?

Ranked on the composite score, Simon S. Jones lead among researchers whose main affiliation is Acetylon Pharmaceuticals (United States).

  1. 1 Simon S. Jones United States · #916,328 worldwide 46 citations · 15 works
All ranked researchers at Acetylon Pharmaceuticals (United States)

Which keywords describe research at Acetylon Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Epigenetic Regulation, Gene Expression, HDAC Inhibitors, Histone Deacetylases, Transcriptional Regulation, BET Bromodomains and PROTACs.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Cancer Therapy14▲ 55×3 topics
  2. Epigenetic Regulation12▲ 142×2 topics
  3. Gene Expression11▲ 43×2 topics
  4. HDAC Inhibitors11▲ 1369×1 topic
  5. Histone Deacetylases11▲ 1369×1 topic
  6. Transcriptional Regulation9▲ 88×4 topics
  7. BET Bromodomains7▲ 857×1 topic
  8. PROTACs7▲ 857×1 topic
  9. Staging System3▲ 132×2 topics
  10. PET Imaging3▲ 35×2 topics
  11. Angiogenesis3▲ 18×3 topics
  12. Proteasome Inhibitors3▲ 105×2 topics
  13. Tumor Microenvironment3▲ 21×3 topics
  14. DNA Methylation3▲ 61×1 topic
  15. Histone Modification3▲ 109×1 topic
  16. Fibroblast Activation Protein3▲ 134×1 topic
  17. Immunosuppression3▲ 59×1 topic
  18. Minimal Residual Disease3▲ 95×2 topics
  19. Diagnosis Criteria2▲ 194×1 topic
  20. Epidemiology2▲ 1.48×5 topics
  21. International Myeloma Working Group2▲ 194×1 topic
  22. Cancer2▲ 3.9×5 topics
  23. Sickle-cell Disease2▲ 104×1 topic
  24. Thalassemia2▲ 104×1 topic
  25. Prognostic Factors2▲ 11×3 topics
  26. Arginine Methylation2▲ 124×1 topic
  27. Protein Arginine Methyltransferases2▲ 124×1 topic
  28. Metastatic Breast Cancer2▲ 59×2 topics
  29. Hematopoietic Stem Cells2▲ 36×2 topics
  30. Quality of Life2▲ 2.7×4 topics
  31. AML1▲ 73×1 topic
  32. Acute Myeloid Leukemia1▲ 73×1 topic
  33. Genetic Mutations1▲ 6.3×4 topics
  34. Chemotherapy-Induced Peripheral Neuropathy1▲ 54×1 topic
  35. Immunotherapy1▲ 4.1×2 topics
  36. Taxanes1▲ 54×1 topic
  37. ALK1▲ 74×1 topic
  38. Neuroblastoma1▲ 74×1 topic

Which research topics does Acetylon Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Lysosomal Storage Disorders Research, Glycogen Storage Diseases and Myoclonus, Trypanosoma species research and implications and Dental Health and Care Utilization.

Lysosomal Storage Disord…0Lysosomal Storage Disorders Research: 0 fractional worksGlycogen Storage Disease…0Glycogen Storage Diseases and Myoclonus: 0 fractional worksTrypanosoma species rese…0Trypanosoma species research and implications: 0 fractional worksDental Health and Care U…0Dental Health and Care Utilization: 0 fractional worksNeuroethics, Human Enhan…0Neuroethics, Human Enhancement, Biomedical Innovations: 0 fractional worksDental Anxiety and Anesthesia Techniques: 0 fractional works
PhysiologyRheumatologyEpidemiologyPeriodontics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lysosomal Storage Disorders Research Physiology 0 works
  2. 2 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works
  3. 3 Trypanosoma species research and implications Epidemiology 0 works
  4. 4 Dental Health and Care Utilization Periodontics 0 works
  5. 5 Neuroethics, Human Enhancement, Biomedical Innovations Cognitive Neuroscience 0 works
  6. 6 Dental Anxiety and Anesthesia Techniques Oral Surgery 0 works
  7. 7 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works
  8. 8 Pain Management and Opioid Use Anesthesiology and Pain Medicine 0 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 0 works
  10. 10 Histone Deacetylase Inhibitors Research Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.9%not open76.1%

World: 28% of research is openly available.

with international co-authors11.5%domestic only88.5%

World: 19% is written across borders.

How has Acetylon Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 94% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.